New hope for stomach cancer patients with abdominal spread

NCT ID NCT05977998

Recruiting now Disease control Sponsor: M.D. Anderson Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether the chemotherapy drug paclitaxel, given before and after stomach removal surgery, can improve outcomes for people with gastric cancer that has spread to the lining of the abdomen. About 30 adults with this condition will receive the drug and be monitored for side effects and survival. The goal is to find a safer, more effective way to treat this advanced cancer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARCINOMATOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

carcinoma gastric adenocarcinoma peritoneal carcinomatosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARCINOMATOSIS GASTRIC ADENOCARCINOMA

Contacts and locations

Locations

M D Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.